Fiscal Year End Company Status Exempt Flag December 31 Delist N Incorporation Locations Inc. Date Expiry Date Country Region Description 29/Aug/1996  22/Jul/2001  USA  Wyoming    Exchange Filing Office Location (not available)		Business Type(s) Primary/Secondary Business Type Details Primary  *Research and Development of Pharmaceutical Products  Pharmaceutical Development  Securities Symbol Security Name Market Status *BAI *BioSante Pharmaceuticals, Inc. TSX Venture DELIST *BAI *Ben-Abraham Technologies Inc TSX Venture DELIST *BAI *Ben-Abraham Technologies Inc ASE DELIST Name History From To *BioSante Pharmaceuticals, Inc. 17/Dec/1999 22/Jul/2001 *Ben-Abraham Technologies Inc. 30/Jun/1992 16/Dec/1999 Company Facts Reconciliation Subject Date Returned Spring 2001 CFR 25/May/2001 Associations Auditing Firm:  *Deloitte & Touche LLP (Vancouver)   *Deloitte & Touche   *Deloitte & Touche (Halifax, NS) Employee:  *Phillip Donenberg   *James Lau   *Claus Wagner-Bartak   *Stephen Simes Investor Relations:  *The Equicom Group Inc. Law Firm:  *Borden Ladner Gervais LLP   *Borden & Elliot Transfer Agent:  *Computershare Trust Company of Canada (Vancouver)   *Computershare Trust Company of Canada (Toronto)   *Montreal Trust Company of Canada (Vancouver)
Latest Information Type Date Title News Releases  9/Jul/2001  NEWS RELEASE - BIOSANTE PHARMACEUTICALS INC. ANNOUNCES VOLUNTARY DELISTING FROM CANADIAN VENTURE EXCHANGE[CANADA NEWSWIRE]     NEWS RELEASE - EFFECTIVE AT THE CLOSE OF BUSINESS JUL 20/01 THE[MARKET NEWS]     NEWS RELEASE - BIOSANTE PHARMACEUTICALS INC. RECEIVES PATENT FOR NEW METHOD OF PROCESSING DRUG PROTEINS[CANADA NEWSWIRE] Bulletins  6/Jul/2001  Delist Meetings and Public Filings    Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations (not available)

* Historical Data